New York, New York (PRWEB) October 18, 2013
As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in courts around the country, Bernstein Liebhard LLP notes that a new study conducted by the Institute for Safe Medicine Practices (ISMP) has found that Pradaxa was associated with more adverse event reports in 2012 than any other medication. According to the ISMP’s latest QuarterWatch report, the U.S. Food & Drug Administration (FDA) tallied 3,292 adverse events and 582 deaths associated with Pradaxa that year. Most of those reports detailed instances of serious internal bleeding, a known Pradaxa side effect for which there is no readily-available antidote.*
“We hear from alleged victims of Pradaxa bleeding side effects on a regular basis. It’s important that patients be aware that there is no known reversal agent for this potentially deadly occurrence,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.
Pradaxa was launched on the market in 2010, and was touted as an improvement over warfarin, a blood thinner that has been in use for decades. According to a recent Bloomberg.com report, Pradaxa has been the subject of regulatory warnings in several countries, mostly due to its association with internal bleeding. While warfarin carries the same risk, internal bleeding that occurs with its use can be quickly staunched with the administration of vitamin K, Bloomberg.com said.**
According to the ISMP’s new QuarterWatch report, warfarin was named in the second-highest number of FDA adverse event reports in 2012. However, the agency received only 861 reports of complications in relation to warfarin use, and just 56 deaths.
This is not the first time the ISMP has raised concerns about Pradaxa bleeding side effects. In January, the group reported that data from the FDA indicated that Pradaxa bleeding was 5 times more likely to be fatal compared to warfarin bleeding.***
Court documents indicate that more than 1,660 Pradaxa bleeding lawsuits are currently pending in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois. Among other things, these lawsuits allege that Boehringer Ingelheim failed to provide adequate warnings to doctors and patients regarding the lack of a readily available antidote to reverse Pradaxa bleeding.
Patients who allegedly suffered serious episodes of internal bleeding while using Pradaxa may be eligible to file a Pradaxa lawsuit to obtain compensation for medical bills, lost wages, pain and suffering and other injury-related damages. Learn More about the potential for Pradaxa bleeding side effects by visiting Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.
*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012
***ismp.org/quarterwatch/pdfs/2012Q2.pdf, ISMP, January 9, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com